Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: A Trial of HRS-5817 in Obese Participants [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating HRS-5817 in obese participants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-5817

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Obesity | EARLY_Phase 1 | Status: RECRUITING